Selective or targeted gene/drug delivery for liver tumors: advantages and current status of local delivery (Q37353096)

19 August 2017

1 reference

title

Selective or targeted gene/drug delivery for liver tumors: advantages and current status of local delivery (English)

1 reference

19 August 2017

1 reference

Young Il Kim

1 reference

19 August 2017

Jin Wook Chung

series ordinal

1 reference

19 August 2017

language of work or name

1 reference

1 December 2008

1 reference

Expert Review of Gastroenterology & Hepatology

19 August 2017

published in

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

19 August 2017

page(s)

791-802

1 reference

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Kupffer cells are central in the removal of nanoparticles from the organism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Therapeutic nanoparticles for drug delivery in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Tumor-activated prodrugs--a new approach to cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Gene delivery to the rat liver using cationic lipid emulsion/DNA complex: comparison between intra-arterial, intraportal and intravenous administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Recent advances in transarterial therapy of primary and secondary liver malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Effect of transcatheter arterial embolization on the boundary architecture of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Iodized oil in the treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Transcatheter arterial chemoembolization with paclitaxel-lipiodol solution in rabbit VX2 liver tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Analysis of radiation-induced liver disease using the Lyman NTCP model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Transcatheter arterial embolization with 188Rhenium-HDD-labeled iodized oil in rabbit VX2 liver tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: results of an IAEA-sponsored multination study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Hepatocellular carcinoma: current management and future trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

New therapies for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Enhanced in vivo adenovirus-mediated gene transfer to rat hepatocarcinomas by selective administration into the hepatic artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Liver failure caused by herpes simplex virus thymidine kinase plus ganciclovir therapy is associated with mitochondrial dysfunction and mitochondrial DNA depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

E1B-deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Suppression of angiogenesis and tumor growth by adenoviral-mediated gene transfer of pigment epithelium-derived factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Intraarterial gene delivery in rabbit hepatic tumors: transfection with nonviral vector by using iodized oil emulsion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Ultrasound with microbubbles enhances gene expression of plasmid DNA in the liver via intraportal delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Endothelial progenitor cells: a source for therapeutic vasculogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Cells as vehicles for therapeutic genes to treat liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Remarkably enhanced expression of the type II hexokinase in rat hepatoma cell line AH130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

FDG-PET for evaluating the antitumor effect of intraarterial 3-bromopyruvate administration in a rabbit VX2 liver tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Antiangiogenic strategies in hepatocellular carcinoma: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Heat-activated liposomal MR contrast agent: initial in vivo results in rabbit liver and kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

New strategies to enhance gene therapy efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Gene therapy by intrahepatic and intratumoral trafficking of p53-VP22 induces regression of liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

Development of cell-specific targeting systems for drugs and genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.791

21 January 2018

Identifiers

DOI

10.1586/17474124.2.6.791

1 reference

19 August 2017

1 reference